---

$0.39

+0.0031 ( +0.79% ) 17.1K

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-10-03	Buy	15132.00	SCHABER CHRISTOPHER J
2025-10-03	Buy	15132.00	SCHABER CHRISTOPHER J
2025-10-03	Buy	15132.00	SCHABER CHRISTOPHER J
2023-12-15	Sale	-38136.00	ZELDIS JEROME B
2023-12-15	Sale	-38136.00	Parks Diane L.
2023-12-15	Sale	-38136.00	RUBIN ROBERT J.
2023-12-15	Sale	-38136.00	LAPOINTE ANTHONY GREGG
2023-12-08	Sale	-90000.00	Donini Oreola
2023-12-08	Sale	-75000.00	Straube Richard
2023-12-08	Sale	-150000.00	SCHABER CHRISTOPHER J